Page last updated: 2024-10-29

iohexol and Mast Cell Activation Disease

iohexol has been researched along with Mast Cell Activation Disease in 1 studies

Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.

Research Excerpts

ExcerptRelevanceReference
"To investigate the mechanism of anaphylactoid reactions to contrast media, in vitro histamine release induced by magnetic resonance imaging, and iodinated contrast agents was examined in a dog mastocytoma cell line."1.29In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media. ( Baxter, AB; Brasch, RC; Lazarus, SC, 1993)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baxter, AB1
Lazarus, SC1
Brasch, RC1

Other Studies

1 other study available for iohexol and Mast Cell Activation Disease

ArticleYear
In vitro histamine release induced by magnetic resonance imaging and iodinated contrast media.
    Investigative radiology, 1993, Volume: 28, Issue:4

    Topics: Anaphylaxis; Animals; Cell Line; Contrast Media; Diatrizoate Meglumine; Dogs; Gadolinium; Gadolinium

1993